{
    "clinical_study": {
        "@rank": "82175", 
        "arm_group": {
            "arm_group_label": "Study Drug", 
            "arm_group_type": "Experimental", 
            "description": "Roflumilast 500 \u03bccg, once daily, for 30 days"
        }, 
        "brief_summary": {
            "textblock": "Our primary hypothesis is that Roflumilast (500 \u03bccg, once daily) will significantly decrease\n      surrogate markers of bone metabolism and early cardiovascular disease in individuals with\n      moderate to severe airflow obstruction and a chronic bronchitis phenotype."
        }, 
        "brief_title": "Roflumilast on Markers of Bone Metabolism and Endothelial Function in COPD", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Chronic Obstructive Pulmonary Disease", 
        "condition_browse": {
            "mesh_term": [
                "Lung Diseases", 
                "Respiration Disorders", 
                "Pulmonary Disease, Chronic Obstructive", 
                "Lung Diseases, Obstructive"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subjects between the ages of 50 and 70 with a minimum of ten-pack years of tobacco\n             exposure, airflow obstruction (FEV1/FVC < 0.70) with an FEV1 < 70%\n\n          -  baseline sputum production at least some of the time as reported on the Saint\n             George's Respiratory Questionnaire, and at least one exacerbation within the past\n             year\n\n        Exclusion Criteria:\n\n          -  Subjects with chronic prednisone use, antiresorptive therapy use (bisphosphonates,\n             calcitonin, parathyroid hormone)\n\n          -  Subjects with a body mass index less than 18 or greater than 34"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "50 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 6, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01745848", 
            "org_study_id": "PRO12060615"
        }, 
        "intervention": {
            "arm_group_label": "Study Drug", 
            "intervention_name": "Roflumilast", 
            "intervention_type": "Drug"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Roflumilast", 
            "COPD"
        ], 
        "lastchanged_date": "November 20, 2013", 
        "location": {
            "contact": {
                "last_name": "Joseph Mastalski"
            }, 
            "facility": {
                "address": {
                    "city": "Pittsburgh", 
                    "country": "United States", 
                    "state": "Pennsylvania", 
                    "zip": "15213"
                }, 
                "name": "Emphysema COPD Research Center"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Effect of Roflumilast on Systemic Markers of Bone Metabolism and Endothelial Function in Patients With Chronic Obstructive Pulmonary Disease", 
        "overall_contact": {
            "email": "mastalskijp@upmc.edu", 
            "last_name": "Joseph Mastalski", 
            "phone": "412-683-7692"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "systemic markers of bone metabolism", 
            "safety_issue": "No", 
            "time_frame": "30 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01745848"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Pittsburgh", 
            "investigator_full_name": "Jessica Bon", 
            "investigator_title": "Assistant Professor of Medicine", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "endothelial function", 
            "safety_issue": "No", 
            "time_frame": "30 days"
        }, 
        "source": "University of Pittsburgh", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Pittsburgh", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2013", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}